Tribal Immunity At The Fed. Circ.: What You Need To Know

Law360 (June 1, 2018, 8:12 PM EDT) -- The Federal Circuit will hear arguments Monday on whether tribal sovereign immunity can insulate patents from review at the Patent Trial and Appeal Board, wading into an issue one judge has suggested could spell the end of the review proceedings.

On one side is Allergan PLC and the Saint Regis Mohawk Tribe, which have teamed up in a deal in which Allergan transferred to the tribe several patents for its dry-eye medication Restasis. On the other side will be a group of generic-drug makers led by Mylan Inc.

Here's everything you need to know about the closely watched case.

What's at...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!